| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |